WO2001016163A3 - Peptide mixture and vaccine against a chronic viral infection - Google Patents
Peptide mixture and vaccine against a chronic viral infection Download PDFInfo
- Publication number
- WO2001016163A3 WO2001016163A3 PCT/EP2000/008124 EP0008124W WO0116163A3 WO 2001016163 A3 WO2001016163 A3 WO 2001016163A3 EP 0008124 W EP0008124 W EP 0008124W WO 0116163 A3 WO0116163 A3 WO 0116163A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hepatitis
- peptide mixture
- viral infection
- vaccine against
- mixture
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 5
- 208000036142 Viral infection Diseases 0.000 title abstract 3
- 230000009385 viral infection Effects 0.000 title abstract 3
- 230000001684 chronic effect Effects 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 208000002672 hepatitis B Diseases 0.000 abstract 3
- 101710132601 Capsid protein Proteins 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 210000000612 antigen-presenting cell Anatomy 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 208000005176 Hepatitis C Diseases 0.000 abstract 1
- 208000037581 Persistent Infection Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001519724A JP2003508409A (en) | 1999-08-27 | 2000-08-21 | Peptide mixtures and vaccines against chronic viral infections |
AU79031/00A AU7903100A (en) | 1999-08-27 | 2000-08-21 | Peptide mixture and vaccine against a chronic viral infection |
EP00969241A EP1206278A2 (en) | 1999-08-27 | 2000-08-21 | Peptide mixture and vaccine against a chronic viral infection |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9903031-4 | 1999-08-27 | ||
SE9903031A SE9903031D0 (en) | 1999-08-27 | 1999-08-27 | Peptide mixture and vaccine against a chronic viral infection |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001016163A2 WO2001016163A2 (en) | 2001-03-08 |
WO2001016163A3 true WO2001016163A3 (en) | 2001-09-07 |
Family
ID=20416772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/008124 WO2001016163A2 (en) | 1999-08-27 | 2000-08-21 | Peptide mixture and vaccine against a chronic viral infection |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1206278A2 (en) |
JP (1) | JP2003508409A (en) |
AU (1) | AU7903100A (en) |
SE (1) | SE9903031D0 (en) |
WO (1) | WO2001016163A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9416416B2 (en) | 2007-10-01 | 2016-08-16 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection/transport compositions and methods |
US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2824326B1 (en) * | 2001-05-04 | 2004-03-19 | Commissariat Energie Atomique | MIXTURE OF PEPTIDES FROM PAPILLOMAVIRUS E6 AND / OR E7 PROTEINS AND THEIR APPLICATIONS |
US7351413B2 (en) | 2002-02-21 | 2008-04-01 | Lorantis, Limited | Stabilized HBc chimer particles as immunogens for chronic hepatitis |
CA2528727A1 (en) * | 2003-06-10 | 2004-12-16 | The University Of Melbourne | Immunomodulating compositions, uses therefor and processes for their production |
GB0608368D0 (en) * | 2006-04-28 | 2006-06-07 | Isis Innovation | Process for making Oligopeptides |
BRPI0713978A2 (en) * | 2006-06-28 | 2012-11-27 | Statens Seruminstitut | expansion of t-cell repertoire to include subdominant epitopes by vaccination with leber antigen such as protein fragments or peptide cocktails |
US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
CA2697373C (en) | 2007-08-27 | 2019-05-21 | Longhorn Vaccines & Diagnostics, Llc | Immunogenic compositions and methods |
EP2106803A1 (en) | 2008-04-04 | 2009-10-07 | Fondazione Centro San Raffaele del Monte Tabor | Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients |
CN102060929A (en) * | 2010-06-07 | 2011-05-18 | 夏书奇 | T-cell immune balance peptide |
JP6758185B2 (en) * | 2013-12-13 | 2020-09-23 | ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ | Multiepitope TARP peptide vaccine and its use |
JP2022535458A (en) * | 2019-06-07 | 2022-08-08 | オレゴン ヘルス アンド サイエンス ユニバーシティ | Hepatitis B virus-specific T-cell responses |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993014206A2 (en) * | 1992-01-20 | 1993-07-22 | Connaught Laboratories Limited | Synthetic peptides for a rubella vaccine |
WO1993018054A2 (en) * | 1992-03-06 | 1993-09-16 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
WO1996022067A2 (en) * | 1994-12-27 | 1996-07-25 | United Biomedical, Inc. | Peptide ratchet libraries for ctl-inducing vaccines and therapeutics |
-
1999
- 1999-08-27 SE SE9903031A patent/SE9903031D0/en unknown
-
2000
- 2000-08-21 WO PCT/EP2000/008124 patent/WO2001016163A2/en not_active Application Discontinuation
- 2000-08-21 EP EP00969241A patent/EP1206278A2/en not_active Withdrawn
- 2000-08-21 JP JP2001519724A patent/JP2003508409A/en active Pending
- 2000-08-21 AU AU79031/00A patent/AU7903100A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993014206A2 (en) * | 1992-01-20 | 1993-07-22 | Connaught Laboratories Limited | Synthetic peptides for a rubella vaccine |
WO1993018054A2 (en) * | 1992-03-06 | 1993-09-16 | N.V. Innogenetics S.A. | Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
WO1996022067A2 (en) * | 1994-12-27 | 1996-07-25 | United Biomedical, Inc. | Peptide ratchet libraries for ctl-inducing vaccines and therapeutics |
Non-Patent Citations (2)
Title |
---|
BRUNA-ROMERO O ET AL: "Induction of Cytotoxic T-Cell Response Against Hepatitis C Virus Structural Antigens Using a Defective Recombinant Adenovirus", HEPATOLOGY, vol. 25, no. 2, 1997, pages 470 - 477, XP002901538 * |
TSAI S L ET AL: "Characterization of T Cell Clones Specific to a Determinant of Hepatitus B Virus Core and e Antigens in Chronic Type B Hepatitus : Implication for a T Cell Mechanism of HBV Immunopathogenesis", J BIOMED SCI, vol. 1, 1994, pages 105 - 118, XP002901537 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
US9416416B2 (en) | 2007-10-01 | 2016-08-16 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection/transport compositions and methods |
Also Published As
Publication number | Publication date |
---|---|
EP1206278A2 (en) | 2002-05-22 |
AU7903100A (en) | 2001-03-26 |
JP2003508409A (en) | 2003-03-04 |
SE9903031D0 (en) | 1999-08-27 |
WO2001016163A2 (en) | 2001-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001016163A3 (en) | Peptide mixture and vaccine against a chronic viral infection | |
Wiktor et al. | Antigenic properties of rabies virus components | |
US7709003B2 (en) | Method of producing an HIV-1 immune response | |
AU2774389A (en) | Recombinant vaccinia virus mva | |
CA2660355A1 (en) | Polynucleotide vaccine formulation against pathologies of the horse | |
DK0596979T3 (en) | Plant virus recombinant nucleic acids | |
NO167359C (en) | PROCEDURE FOR THE PREPARATION OF A VACCINE AGAINST INFECTION OF HEPATITIS B VIRUS. | |
DE68928130D1 (en) | Synthetic peptides derived from HIV-GP120-env protein and their application | |
ES2075440T3 (en) | VACCINE AGAINST HEPATITIS B. | |
WO2004004761A3 (en) | Adjuvant viral particle | |
RU2319505C2 (en) | Purified coat proteins of hepatitis c virus for diagnostic and therapeutic application | |
WO2002074920A3 (en) | A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same | |
IE870507L (en) | Bovine virus diarrhea and hog cholera vaccines | |
EP0327180A3 (en) | Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1 | |
EP1878797A3 (en) | Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same | |
KR950005326A (en) | Recombinant Adenovirus Vaccine | |
US4946676A (en) | Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide | |
RU2313363C2 (en) | Hepatitis virus c envelope purified protein for diagnostic and therapeutic application | |
WO2007127290A3 (en) | Method for producing viral vaccine and therapeutic peptide antigens | |
WO2001055330A3 (en) | Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses | |
GB9925966D0 (en) | Threapeutic vaccines against variable viruses and other targets | |
AU6839598A (en) | Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection | |
WO2002089728A3 (en) | Recombinant rhabdoviruses as live-viral vaccines | |
AU2004200155C1 (en) | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV | |
Ivanoff et al. | Human immunodeficiency virus antigen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000969241 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000969241 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10069109 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000969241 Country of ref document: EP |